{"entity":{"type":"insider","cik":"0001326609","url":"/insider/0001326609","json_url":"/insider/0001326609.json","name":"Ferguson Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":229,"n_filings":41,"first":"2007-02-09","last":"2008-01-30","span_basis":"filed_date"},"name_variants":[{"name":"Ferguson Patrick","source":"filing","n_filings":41,"first_seen":"2007-02-09","last_seen":"2008-01-30"}],"transactions":[{"id":2959276,"accession":"0000795551-08-000007","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000795551-08-000007","line_url":"/filing/0000795551-08-000007","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12600.0,"shares_display":"12,600","price_per_share":3.515029365079365,"price_display":"3.52","price_state":"stated","total_value":44289.37,"total_display":"44,289.37","total_whole":"44,289","shares_owned_after":1266233.0,"shares_owned_after_display":"1,266,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-29","filed_date":"2008-01-30","scope":"insider","n_lines":8},{"id":3610555,"accession":"0000795551-08-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000795551-08-000006","line_url":"/filing/0000795551-08-000006","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.482407,"price_display":"3.48","price_state":"stated","total_value":34824.07,"total_display":"34,824.07","total_whole":"34,824","shares_owned_after":1273233.0,"shares_owned_after_display":"1,273,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-24","filed_date":"2008-01-24","scope":"insider","n_lines":6},{"id":9200343,"accession":"0000795551-08-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000795551-08-000005","line_url":"/filing/0000795551-08-000005#line-1","is_derivative":false,"issuer_cik":"0001326609","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0001326609","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":3.66,"price_display":"3.66","price_state":"stated","total_value":16836.0,"total_display":"16,836.00","total_whole":"16,836","shares_owned_after":1290584.0,"shares_owned_after_display":"1,290,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-18","filed_date":"2008-01-22","scope":"insider"},{"id":2420368,"accession":"0000795551-08-000004","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000795551-08-000004","line_url":"/filing/0000795551-08-000004","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":3.9789013333333334,"price_display":"3.98","price_state":"stated","total_value":59683.52,"total_display":"59,683.52","total_whole":"59,684","shares_owned_after":1290584.0,"shares_owned_after_display":"1,290,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-18","filed_date":"2008-01-22","scope":"insider","n_lines":10},{"id":2420316,"accession":"0000795551-08-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000795551-08-000004","line_url":"/filing/0000795551-08-000004#line-1","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":3.89,"price_display":"3.89","price_state":"stated","total_value":15171.0,"total_display":"15,171.00","total_whole":"15,171","shares_owned_after":1298558.0,"shares_owned_after_display":"1,298,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-17","filed_date":"2008-01-22","scope":"insider"},{"id":3559026,"accession":"0000795551-08-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000795551-08-000003","line_url":"/filing/0000795551-08-000003","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8500.0,"shares_display":"8,500","price_per_share":3.89508,"price_display":"3.90","price_state":"stated","total_value":33108.18,"total_display":"33,108.18","total_whole":"33,108","shares_owned_after":1307058.0,"shares_owned_after_display":"1,307,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-16","filed_date":"2008-01-17","scope":"insider","n_lines":4},{"id":6779983,"accession":"0000795551-07-000060","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000795551-07-000060","line_url":"/filing/0000795551-07-000060","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":3.8181629629629628,"price_display":"3.82","price_state":"stated","total_value":10309.04,"total_display":"10,309.04","total_whole":"10,309","shares_owned_after":1310958.0,"shares_owned_after_display":"1,310,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-20","filed_date":"2007-12-20","scope":"insider","n_lines":3},{"id":6779974,"accession":"0000795551-07-000060","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000795551-07-000060","line_url":"/filing/0000795551-07-000060","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12200.0,"shares_display":"12,200","price_per_share":3.921689344262295,"price_display":"3.92","price_state":"stated","total_value":47844.61,"total_display":"47,844.61","total_whole":"47,845","shares_owned_after":1322158.0,"shares_owned_after_display":"1,322,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-19","filed_date":"2007-12-20","scope":"insider","n_lines":9},{"id":8346720,"accession":"0000795551-07-000059","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000795551-07-000059","line_url":"/filing/0000795551-07-000059#line-12","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5800.0,"shares_display":"5,800","price_per_share":3.9,"price_display":"3.90","price_state":"stated","total_value":22620.0,"total_display":"22,620.00","total_whole":"22,620","shares_owned_after":1345058.0,"shares_owned_after_display":"1,345,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"},{"id":8346716,"accession":"0000795551-07-000059","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000795551-07-000059","line_url":"/filing/0000795551-07-000059#line-11","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":3.94,"price_display":"3.94","price_state":"stated","total_value":13790.0,"total_display":"13,790.00","total_whole":"13,790","shares_owned_after":1337058.0,"shares_owned_after_display":"1,337,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"},{"id":8346713,"accession":"0000795551-07-000059","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000795551-07-000059","line_url":"/filing/0000795551-07-000059#line-10","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":1327858.0,"shares_owned_after_display":"1,327,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"},{"id":8346710,"accession":"0000795551-07-000059","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000795551-07-000059","line_url":"/filing/0000795551-07-000059#line-9","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":3.92,"price_display":"3.92","price_state":"stated","total_value":11368.0,"total_display":"11,368.00","total_whole":"11,368","shares_owned_after":1340758.0,"shares_owned_after_display":"1,340,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"},{"id":8346707,"accession":"0000795551-07-000059","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000795551-07-000059","line_url":"/filing/0000795551-07-000059#line-8","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":3.95,"price_display":"3.95","price_state":"stated","total_value":9480.0,"total_display":"9,480.00","total_whole":"9,480","shares_owned_after":1333458.0,"shares_owned_after_display":"1,333,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"},{"id":8346704,"accession":"0000795551-07-000059","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000795551-07-000059","line_url":"/filing/0000795551-07-000059#line-7","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":3.99,"price_display":"3.99","price_state":"stated","total_value":7980.0,"total_display":"7,980.00","total_whole":"7,980","shares_owned_after":1325858.0,"shares_owned_after_display":"1,325,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"},{"id":8346699,"accession":"0000795551-07-000059","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000795551-07-000059","line_url":"/filing/0000795551-07-000059#line-6","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":3.96,"price_display":"3.96","price_state":"stated","total_value":5940.0,"total_display":"5,940.00","total_whole":"5,940","shares_owned_after":1330858.0,"shares_owned_after_display":"1,330,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"},{"id":8346693,"accession":"0000795551-07-000059","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000795551-07-000059","line_url":"/filing/0000795551-07-000059#line-5","is_derivative":false,"issuer_cik":"0000795551","issuer_name":"THERAGENICS CORP","issuer_ticker":"TGX","issuer_name_source":null,"issuer_url":"/issuer/0000795551","owner_cik":"0001326609","owner_name":"Ferguson Patrick","owner_display_name":"Ferguson Patrick","owner_url":"/insider/0001326609","role":"Officer (President, CP Medical)","role_mark":"O","role_mark_label":"Officer (President, CP Medical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CP Medical","security_title":"Theragenics Corporation common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":3.9401,"price_display":"3.94","price_state":"stated","total_value":4728.12,"total_display":"4,728.12","total_whole":"4,728","shares_owned_after":1335858.0,"shares_owned_after_display":"1,335,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-14","filed_date":"2007-12-17","scope":"insider"}],"collapsed":true,"next_cursor":"2007-12-14|8346693","ledger_fault":false,"count":{"value":229,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":229,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":229},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000795551","name":"THERAGENICS CORP","url":"/issuer/0000795551","role":"Officer (President, CP Medical)","n_filings":41,"first_seen":"2007-02-09","last_seen":"2008-01-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001326609","retrieved_at":"2026-08-22T17:05:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}